These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 2555821)

  • 21. Human red cells enhance the formation of 5-lipoxygenase-derived products by neutrophils.
    Stern A; Serhan CN
    Free Radic Res Commun; 1989; 7(3-6):335-9. PubMed ID: 2555280
    [TBL] [Abstract][Full Text] [Related]  

  • 22. U-60,257 has no effect on the metabolism of arachidonic acid in nonstimulated human polymorphonuclear leukocytes.
    Dahl ML; Puustinen T; Uotila P
    Res Commun Chem Pathol Pharmacol; 1984 Jun; 44(3):355-65. PubMed ID: 6431565
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Metabolism of arachidonic acid through the 5-lipoxygenase pathway in normal human peritoneal macrophages.
    Laviolette M; Carreau M; Coulombe R; Cloutier D; Dupont P; Rioux J; Braquet P; Borgeat P
    J Immunol; 1988 Sep; 141(6):2104-9. PubMed ID: 2844895
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Modulation of the generation and release of leukotrienes from leukocytes.
    Lewis RA
    Prog Clin Biol Res; 1985; 199():163-72. PubMed ID: 2999819
    [No Abstract]   [Full Text] [Related]  

  • 25. [Leukotriene synthesis by gastrointestinal tissue and its pharmacologic modification].
    Peskar BM; Kozuschek W; Morgenroth K; Hoppe U; Dreyling KW; Peskar BA
    Wien Klin Wochenschr; 1986 Feb; 98(4):98-104. PubMed ID: 3010577
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The 6R-oxygenase activity of arachidonate 5-lipoxygenase purified from porcine leukocytes.
    Ueda N; Yamamoto S
    J Biol Chem; 1988 Feb; 263(4):1937-41. PubMed ID: 3338999
    [TBL] [Abstract][Full Text] [Related]  

  • 27. On the mechanism of biosynthesis of 5- and 15-series leukotrienes.
    Brash AR; Maas RL; Oates JA
    J Allergy Clin Immunol; 1984 Sep; 74(3 Pt 2):316-23. PubMed ID: 6088609
    [No Abstract]   [Full Text] [Related]  

  • 28. Arachidonic acid metabolism.
    Needleman P; Turk J; Jakschik BA; Morrison AR; Lefkowith JB
    Annu Rev Biochem; 1986; 55():69-102. PubMed ID: 3017195
    [No Abstract]   [Full Text] [Related]  

  • 29. Inhibition of human neutrophils by auranofin: chemotaxis and metabolism of arachidonate via the 5-lipoxygenase pathway.
    Elmgreen J; Ahnfelt-Rønne I; Nielsen OH
    Ann Rheum Dis; 1989 Feb; 48(2):134-8. PubMed ID: 2539060
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Polymorphonuclear leukocyte 5-lipoxygenase activity in psoriasis.
    Ruzicka T; Radspieler H; Strasser T; Przybilla B; Ring J
    Prostaglandins Leukot Med; 1985 Jun; 18(3):313-9. PubMed ID: 2991947
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of dietary vitamin E on the biosynthesis of 5-lipoxygenase products by rat polymorphonuclear leukocytes (PMNL).
    Chan AC; Tran K; Pyke DD; Powell WS
    Biochim Biophys Acta; 1989 Oct; 1005(3):265-9. PubMed ID: 2508746
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 5- and 15(omega-6)-lipoxygenases from human polymorphonuclear leukocytes.
    Soberman RJ
    Methods Enzymol; 1988; 163():344-9. PubMed ID: 3070300
    [No Abstract]   [Full Text] [Related]  

  • 33. Lipoxygenase pathways of macrophages.
    Bonney RJ; Opas EE; Humes JL
    Fed Proc; 1985 Nov; 44(14):2933-6. PubMed ID: 2996948
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterization of CGS 8515 as a selective 5-lipoxygenase (5-LO) inhibitor.
    Ku EC; Raychaudhuri A; Ghai G; Kimble EF; Lee WH; Colombo C; Dotson R; White D; Oglesby TD; Wasley JW
    Adv Prostaglandin Thromboxane Leukot Res; 1989; 19():86-9. PubMed ID: 2526568
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Subcellular localization of leukotriene-forming enzymes.
    Jakschik BA; Kuo CG
    Adv Prostaglandin Thromboxane Leukot Res; 1983; 11():141-5. PubMed ID: 6221516
    [No Abstract]   [Full Text] [Related]  

  • 36. Pure enzymes in a test hierarchy for antibronchoconstrictory lipoxygenase inhibitors.
    Slapke J; Schewe T; Kühn H; Rapoport SM
    Biomed Biochim Acta; 1986; 45(10):1267-75. PubMed ID: 3105528
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Arachidonate 15-lipoxygenase from human eosinophil-enriched leukocytes: partial purification and properties.
    Sigal E; Grunberger D; Cashman JR; Craik CS; Caughey GH; Nadel JA
    Biochem Biophys Res Commun; 1988 Jan; 150(1):376-83. PubMed ID: 3337718
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An analysis of the relationship between 5-lipoxygenase product generation and the secretion of preformed mediators from mouse bone marrow-derived mast cells.
    Razin E; Romeo LC; Krilis S; Liu FT; Lewis RA; Corey EJ; Austen KF
    J Immunol; 1984 Aug; 133(2):938-45. PubMed ID: 6330206
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Arachidonic acid-induced pleurisy (ARIP): an in vivo model for testing 5-lipoxygenase inhibition.
    Boctor AM; Burke C; Hovinga ME
    Methods Find Exp Clin Pharmacol; 1987 Dec; 9(12):793-7. PubMed ID: 2831442
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intracellular retention of the 5-lipoxygenase pathway product, leukotriene B4, by human neutrophils activated with unopsonized zymosan.
    Williams JD; Lee TH; Lewis RA; Austen F
    J Immunol; 1985 Apr; 134(4):2624-30. PubMed ID: 2982947
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.